NUP214-ABL1阳性T细胞急性淋巴细胞白血病患者复发后对伊马替尼治疗显示出初步良好反应。 - Suppr

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

作者信息

Clarke Sarah, O'Reilly John, Romeo Giuliana, Cooney Julian

出版信息

Leuk Res. 2011 Jul;35(7):e131-3. doi: 10.1016/j.leukres.2011.03.025. Epub 2011 Apr 13.

DOI:10.1016/j.leukres.2011.03.025

PMID:21489623

Abstract

摘要

相似文献

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

Leuk Res. 2011 Jul;35(7):e131-3. doi: 10.1016/j.leukres.2011.03.025. Epub 2011 Apr 13.

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.

Nat Genet. 2004 Oct;36(10):1084-9. doi: 10.1038/ng1425. Epub 2004 Sep 12.

Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.

Pediatr Blood Cancer. 2012 Aug;59(2):333-4. doi: 10.1002/pbc.23327. Epub 2012 Jan 3.

ABL1 rearrangements in T-cell acute lymphoblastic leukemia.

Genes Chromosomes Cancer. 2010 Apr;49(4):299-308. doi: 10.1002/gcc.20743.

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia.

Leuk Res. 2009 Jul;33(7):e73-4. doi: 10.1016/j.leukres.2008.11.009. Epub 2008 Dec 23.

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.

Cancer. 2005 Apr 15;103(8):1659-69. doi: 10.1002/cncr.20922.

Detection of a cryptic gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia.

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.

T-cell acute lymphoblastic leukemia associated with complex karyotype and SET-NUP214 rearrangement: a case study and review of the literature.

Ann Clin Lab Sci. 2011 Summer;41(3):267-72.

NUP214-ABL1 in adult T-ALL: the GMALL study group experience.

Blood. 2006 Nov 15;108(10):3556-9. doi: 10.1182/blood-2006-04-014514. Epub 2006 Jul 27.

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.

Leukemia. 2005 Sep;19(9):1680-1. doi: 10.1038/sj.leu.2403877.

引用本文的文献

fusion genes in acute leukemias: genetic characterization of rare cases.

Front Oncol. 2024 Mar 20;14:1371980. doi: 10.3389/fonc.2024.1371980. eCollection 2024.

Current perspectives in T-ALL.

Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000259. eCollection 2019 Jun.

Case Report: The First Report of Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.

Front Oncol. 2021 Jul 8;11:706798. doi: 10.3389/fonc.2021.706798. eCollection 2021.

The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Cold Spring Harb Perspect Med. 2020 Mar 2;10(3):a035246. doi: 10.1101/cshperspect.a035246.

Detection of a cryptic gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia.

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.

Relapsed T Cell ALL: Current Approaches and New Directions.

Curr Hematol Malig Rep. 2019 Apr;14(2):83-93. doi: 10.1007/s11899-019-00501-3.

Can one target T-cell ALL?

Best Pract Res Clin Haematol. 2018 Dec;31(4):361-366. doi: 10.1016/j.beha.2018.10.001. Epub 2018 Oct 17.

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.

Cancer Cell. 2018 Aug 13;34(2):271-285.e7. doi: 10.1016/j.ccell.2018.07.007.

Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.

Mol Cytogenet. 2017 Oct 26;10:39. doi: 10.1186/s13039-017-0340-6. eCollection 2017.

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.

Oncotarget. 2016 Nov 29;7(48):79842-79853. doi: 10.18632/oncotarget.13035.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

作者信息

出版信息

相似文献

引用本文的文献